CHP
IMUX icon

Cable Hill Partners’s Immunic IMUX Stock Holding History

Cable Hill Partners’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$8K – 401
2019
Q1 		$8K Buy
100
+12
+14% +$1.05K ﹤0.01% 517
2018
Q4 		$7K Buy
88
+38
+76% +$4.45K ﹤0.01% 504
2018
Q3 		$8K Buy
+50
New +$131K ﹤0.01% 472

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cable Hill Partners's IMUX Position: Q2 2019 in Review

Cable Hill Partners sold out of Immunic (IMUX) in Q2 2019, closing a stake of 100 shares — an estimated $8K sold.

Cable Hill Partners first reported a position in IMUX in Q3 2018 and held it in 3 quarters. The position peaked at $8K in Q1 2019. 24 funds tracked by Wall St. Rank hold IMUX as of Q2 2019.

  • Cable Hill Partners reported no remaining Immunic position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 100 Immunic shares in Q2 2019, an estimated $8K.
  • Cable Hill Partners first reported a position in Immunic in Q3 2018 and held it in 3 quarters.
  • Cable Hill Partners's Immunic position peaked at $8K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Immunic as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.